STAT July 8, 2024
Anna Wexler

Medical milestones broadcast via tweet. Scientific progress revealed via live YouTube demo. Teasers for updates followed by a livestream from a patient’s home. These aren’t the latest social media influencer tactics, but the way Neuralink, Elon Musk’s neurotechnology company, has disseminated information about its medical research.

Neuralink’s unconventional approaches to research have challenged many norms of medical science. Instead of attending scientific conferences and sharing interim progress, Neuralink has communicated information via social media, oscillating between extreme secrecy and openness. This strategy has left the scientific community playing catch-up, scrambling to glean insights from tweets and YouTube videos.

Rather than transparently sharing information about its ongoing clinical trial, Neuralink has kept details about it tightly guarded. The company’s unusual decision...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article